相关实验视频
Updated: Feb 8, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.3K
标本性肥胖症的内分泌学方面
Marianna Minnetti1, Eleonora Poggiogalle1, Francesco Frigerio2
1Department of Experimental Medicine, Sapienza University, Rome, Italy.
Annals of medicine
|February 6, 2026
概括
肥胖症涉及多余的脂肪和肌肉损失,由内分泌功能障碍驱动. 了解荷尔蒙失衡是开发这种疾病新疗法的关键.
科学领域:
- 内分泌学 在内分泌学.
- 代谢过程中的代谢.
- 老年学是一门学科.
背景情况:
- 肥胖症 (sarcopenic obesity,SO) 是一种复杂的疾病,由多余的脂肪和减少的肌肉质量和功能来定义.
- 它的致病性涉及复杂的代谢,炎症和内分泌通路,破坏了合成代谢-代谢平衡.
研究的目的:
- 阐明内分泌功能障碍在肥胖症中的作用.
- 探索内分泌疾病作为SO研究的模型.
- 为了确定SO治疗的新型荷尔蒙点.
主要方法:
- 关于SO中的内分泌机制的当前文献的综述.
- 激素失衡的分析,有助于改变脂肪肌肉交叉.
- 研究与年龄相关的荷尔蒙变化和模仿SO特征的特定内分泌疾病.
主要成果:
- 内分泌功能障碍通过促进线粒体功能障碍,氧化应激和炎症显著推动SO.
- 荷尔蒙变化,包括与年龄相关的衰退和诸如阴性腺体和甲状腺功能低下等疾病,加剧胰岛素抵抗,肌肉代谢和脂肪积累.
- 特定的内分泌疾病作为有价值的模型来了解SO的潜在机制.
结论:
- 对内分泌通路的综合研究对于理解SO至关重要.
- 准荷尔蒙失衡为精确疗法提供了潜在的潜力.
- 为了改善代谢和功能结果,需要对代谢/抗代谢剂和内分泌模型进行进一步的研究.
相关概念视频
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Quantitative Aspects of Drug-Receptor Interaction
1.8K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.8K
Drug Dosing: Obese Patients
269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
287
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
287
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
191
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
191
Self-Schemas
36.4K
In general, a schema is a mental construct consisting of a cluster or collection of related concepts (Bartlett, 1932). There are many different types of schemata, and they all have one thing in common: schemata are a method of organizing information that allows the brain to work more efficiently. When a schema is activated, the brain makes immediate assumptions about the person or object being observed.
36.4K

